MCHP

Microchip Technology
D

MCHP

Arincen49/100B

Microchip Technology free cash flow 1993–2027

Microchip Technology's free cash flow in Q2 FY2027, the three months to 30 September 2026, was 396.10M USD, up 667.6% on the same quarter a year before. Microchip Technology's free cash flow over the last twelve months was 1.46B USD, up 92.9% on the twelve months before. In fiscal year 2026 it was 871.00M USD, up 12.8% on the year before.

Last updated 6 Nov 2026 · Next report 4 Feb 2027

Free cash flow

Free cash flow · +3.0% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM30 Sept 20261.46B+92.92%25.97%1.53B-73.70M—
FY202631 Mar 2026871.00M+12.81%18.48%962.10M-91.10M1.59
FY202531 Mar 2025772.10M-70.39%17.54%898.10M-126.00M1.44
FY202431 Mar 20242.61B-16.82%34.16%2.89B-285.10M4.76
FY202331 Mar 20233.13B+26.78%37.15%3.62B-486.20M5.62
FY202231 Mar 20222.47B+35.57%36.25%2.84B-370.10M4.37
FY202131 Mar 20211.82B+23.55%33.54%1.92B-92.60M3.37
FY202031 Mar 20201.48B+2.10%27.99%1.54B-67.60M2.88
FY201931 Mar 20191.45B+19.22%27.03%1.67B-228.90M2.89
FY201831 Mar 20181.21B+23.23%30.47%1.42B-206.80M2.44
FY201731 Mar 2017984.14M+52.21%28.88%1.06B-75.31M2.10
FY201631 Mar 2016646.59M+13.10%29.75%744.48M-97.90M1.49
FY201531 Mar 2015571.71M+1.46%26.63%721.18M-149.47M1.28
FY201431 Mar 2014563.49M+42.53%29.18%676.56M-113.07M1.29
FY201331 Mar 2013395.36M+18.34%25.00%446.18M-50.82M0.96
FY201231 Mar 2012334.09M-27.09%24.15%396.46M-62.37M0.82
FY201131 Mar 2011458.21M+13.29%30.81%582.66M-124.45M1.18
FY201031 Mar 2010404.44M+96.06%42.67%452.05M-47.60M1.08
FY200931 Mar 2009206.28M-45.35%22.84%308.65M-102.37M0.55
FY200831 Mar 2008377.48M+2.10%36.45%447.31M-69.83M0.89
FY200731 Mar 2007369.73M+2.41%35.56%429.77M-60.04M0.84
FY200631 Mar 2006361.03M+24.71%38.91%437.32M-76.29M0.84
FY200531 Mar 2005289.50M+3.55%34.18%352.71M-63.21M0.68
FY200431 Mar 2004279.57M+55.49%39.98%343.08M-63.51M0.66
FY200331 Mar 2003179.80M+34.04%27.60%260.19M-80.39M0.43
FY200231 Mar 2002134.14M—23.48%178.83M-44.69M0.32
FY200131 Mar 2001-186.78M-783.41%-26.10%254.36M-441.15M-0.46
FY200031 Mar 200027.33M-56.62%5.51%239.69M-212.36M0.07
FY199931 Mar 199963.00M—15.50%102.64M-39.64M0.16
FY199831 Mar 1998-8.76M—-2.21%136.54M-145.30M-0.02
FY199731 Mar 1997-1.43M—-0.43%77.59M-79.01M-0.00
FY199631 Mar 1996-42.40M—-14.83%73.40M-115.80M-0.11
FY199531 Mar 1995-27.70M—-13.32%43.10M-70.80M-0.08
FY199431 Mar 1994-900.00K-117.65%-0.65%34.50M-35.40M-0.00
FY199331 Mar 19935.10M—5.75%7.60M-2.50M0.02

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about Microchip Technology's free cash flow

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.